EGFR and cancer: As shown in Figure 5B, the top 10 pathways included human cytomegalovirus infection (hsa05163), AGE-RAGE signaling pathway in diabetic complications (hsa04933), coronavirus disease–COVID-19 (hsa05171), inflammatory bowel disease (hsa05321), EGFR tyrosine kinase inhibitor resistance (hsa01521), rheumatoid arthritis (hsa05323), HIF-1 signaling pathway (hsa04066), antifolate resistance (hsa01523), proteoglycans in cancer (hsa05205), and African trypanosomiasis (hsa05143).